Published April 1, 2019 | Version v1
Journal article Open

Assessing Amyloid Pathology in Cognitively Normal Subjects Using 18 F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods

  • 1. Deptartment of Radiology and Nuclear Medicine, VU Medical Center, Amsterdam, The Netherlands
  • 2. Alzheimer Center and Department of Neurology, VU Medical Center, Amsterdam, The Netherlands
  • 3. Deptartment of Radiology and Nuclear Medicine, VU Medical Center, Amsterdam, The Netherlands ; Centre of Radiology, North Estonia Medical Centre, Tallinn, Estonia ; Department of Health Technologies, Tallinn University of Technology, Tallinn, Estonia
  • 4. Alzheimer Center and Department of Neurology, VU Medical Center, Amsterdam, The Netherlands ; Department of Biological Psychology, VU Amsterdam, The Netherlands
  • 5. Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
  • 6. Deptartment of Radiology and Nuclear Medicine, VU Medical Center, Amsterdam, The Netherlands ; Institute of Neurology and Healthcare Engineering, University College London, London, United Kingdom

Description

Abstract:
Our objective was to determine the optimal approach for assessing amyloid disease in a cognitively normal elderly population. Methods: Dynamic 18F-flutemetamol PET scans were acquired using a coffee-break protocol (a 0- to 30-min scan and a 90- to 110-min scan) on 190 cognitively normal elderly individuals (mean age, 70.4 y; 60% female). Parametric images were generated from SUV ratio (SUVr) and nondisplaceable binding potential (BPND) methods, with cerebellar gray matter as a reference region, and were visually assessed by 3 trained readers. Interreader agreement was calculated using κ-statistics, and semiquantitative values were obtained. Global cutoffs were calculated for both SUVr and BPND using a receiver-operating-characteristic analysis and the Youden index. Visual assessment was related to semiquantitative classifications. Results: Interreader agreement in visual assessment was moderate for SUVr (κ = 0.57) and good for BPND images (κ = 0.77). There was discordance between readers for 35 cases (18%) using SUVr and for 15 cases (8%) using BPND, with 9 overlapping cases. For the total cohort, the mean (±SD) SUVr and BPND were 1.33 (±0.21) and 0.16 (±0.12), respectively. Most of the 35 cases (91%) for which SUVr image assessment was discordant between readers were classified as negative based on semiquantitative measurements. Conclusion: The use of parametric BPND images for visual assessment of 18F-flutemetamol in a population with low amyloid burden improves interreader agreement. Implementing semiquantification in addition to visual assessment of SUVr images can reduce false-positive classification in this population.

Notes

This project received funding from the EU/EFPIA Innovative Medicines Initiative (IMI) Joint Undertaking (EMIF grant 115372) and the EU-EFPIA IMI-2 Joint Undertaking (grant 115952). This joint undertaking receives support from the European Union's Horizon 2020 research and innovation program and EFPIA. Support was also received from the NIHR UCLH Biomedical Research Center, and in-kind sponsoring of the PET tracer was received from GE Healthcare. This publication solely reflects the author's view and neither IMI nor the European Union, and EFPIA are responsible for any use that may be made of the information contained herein.

Files

Assessing Amyloid Pathology in Cognitively Normal Subjects.pdf

Files (1.0 MB)

Additional details

Funding

European Commission
AMYPAD – Amyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952 115952
European Commission
EMIF – European Medical Information Framework 115372